Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study.

Ashruf, Omer S; Orozco, Zara; Kaelber, David C

Ashruf, Omer S; Orozco, Zara; Kaelber, David C.

Afiliação

Ashruf OS; Northeast Ohio Medical University, College of Medicine, Rootstown, OH, United States. Electronic address: oashruf@neomed.edu.
Orozco Z; Northeast Ohio Medical University, College of Medicine, Rootstown, OH, United States.
Kaelber DC; Center for Education and Training in Health Informatics, The Metro Health System and the Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States.

Clin Lymphoma Myeloma Leuk ; 23(8): 626-632, 2023 08.

Article em En | MEDLINE | ID: mdl-37208255

Assuntos

COVID-19; Gamopatia Monoclonal de Significância Indeterminada; Mieloma Múltiplo; Humanos; Gamopatia Monoclonal de Significância Indeterminada/complicações; Gamopatia Monoclonal de Significância Indeterminada/epidemiologia; Estudos de Coortes; Estudos Retrospectivos; Progressão da Doença; COVID-19/complicações; COVID-19/epidemiologia; Mieloma Múltiplo/complicações; Mieloma Múltiplo/epidemiologia

Palavras-chave

Immunoglobulin M light chain; M protein; Multiple myeloma; Plasma cell dyscrasia; Viral infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / COVID-19 / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google